Literature DB >> 17374851

Molecular coordination of hepatic glucose metabolism by the 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase:glucokinase complex.

W Ed Smith1, Sara Langer, Chaodong Wu, Simone Baltrusch, David A Okar.   

Abstract

Glucokinase (GK) and 6-phosphofructo-2-kinase (PFK-2)/fructose-2,6-bisphosphatase (FBP-2) are each powerful regulators of hepatic carbohydrate metabolism that have been reported to influence each other's expression, activities, and cellular location. Here we present the first physical evidence for saturable and reversible binding of GK to the FBP-2 domain of PFK-2/FBP-2 in a 1:1 stoichiometric complex. We confirmed complex formation and stoichiometry by independent methods including affinity resin pull-down assays and fluorescent resonance energy transfer. All suggest that the binding of GK to PFK-2/FBP-2 is weak. Enzymatic assays of the GK:PFK-2/FBP-2 complex suggest a concomitant increase of the kinase-to-bisphosphatase ratio of bifunctional enzyme and activation of GK upon binding. The kinase-to-bisphosphatase ratio is increased by activation of the PFK-2 activity whereas FBP-2 activity is unchanged. This means that the GK-bound PFK-2/FBP-2 produces more of the biofactor fructose-2,6-bisphosphate, a potent activator of 6-phosphofructo-1-kinase, the committing step to glycolysis. Therefore, we conclude that the binding of GK to PFK-2/FBP-2 promotes a coordinated up-regulation of glucose phosphorylation and glycolysis in the liver, i.e. hepatic glucose disposal. The GK:PFK-2/FBP-2 interaction may also serve as a metabolic signal transduction pathway for the glucose sensor, GK, in the liver. Demonstration of molecular coordination of hepatic carbohydrate metabolism has fundamental relevance to understanding the function of the liver in maintaining fuel homeostasis, particularly in managing excursions in glycemia produced by meal consumption.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374851     DOI: 10.1210/me.2006-0356

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  13 in total

1.  A fundamental trade-off in covalent switching and its circumvention by enzyme bifunctionality in glucose homeostasis.

Authors:  Tathagata Dasgupta; David H Croll; Jeremy A Owen; Matthew G Vander Heiden; Jason W Locasale; Uri Alon; Lewis C Cantley; Jeremy Gunawardena
Journal:  J Biol Chem       Date:  2014-03-14       Impact factor: 5.157

2.  Endogenous activation of glucokinase by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is glucose dependent.

Authors:  Sara Langer; Martin T Kaminski; Sigurd Lenzen; Simone Baltrusch
Journal:  Mol Endocrinol       Date:  2010-08-11

3.  Continuous low-dose fructose infusion does not reverse glucagon-mediated decrease in hepatic glucose utilization.

Authors:  Paulette M Johnson; Sheng-Song Chen; Tammy S Santomango; Phillip E Williams; D Brooks Lacy; Owen P McGuinness
Journal:  Metabolism       Date:  2010-10-12       Impact factor: 8.694

4.  Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis.

Authors:  Yaoyao Zou; Shan Zeng; Mingcheng Huang; Qian Qiu; Youjun Xiao; Maohua Shi; Zhongping Zhan; Liuqin Liang; Xiuyan Yang; Hanshi Xu
Journal:  Br J Pharmacol       Date:  2017-03-27       Impact factor: 8.739

Review 5.  Molecular and cellular regulation of human glucokinase.

Authors:  Shawn M Sternisha; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2019-01-11       Impact factor: 4.013

6.  Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases.

Authors:  Abdullah Yalcin; Brian F Clem; Alan Simmons; Andrew Lane; Kristin Nelson; Amy L Clem; Erin Brock; Deanna Siow; Binks Wattenberg; Sucheta Telang; Jason Chesney
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

7.  Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death.

Authors:  Eric C Cheung; Robert L Ludwig; Karen H Vousden
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

8.  Identification of the ubiquitin-like domain of midnolin as a new glucokinase interaction partner.

Authors:  Anke Hofmeister-Brix; Katrin Kollmann; Sara Langer; Julia Schultz; Sigurd Lenzen; Simone Baltrusch
Journal:  J Biol Chem       Date:  2013-11-01       Impact factor: 5.157

9.  Susceptibility of glucokinase-MODY mutants to inactivation by oxidative stress in pancreatic β-cells.

Authors:  Kirsty S Cullen; Franz M Matschinsky; Loranne Agius; Catherine Arden
Journal:  Diabetes       Date:  2011-10-25       Impact factor: 9.461

10.  Phosphofructo-2-kinase/fructose-2,6-bisphosphatase modulates oscillations of pancreatic islet metabolism.

Authors:  Matthew J Merrins; Richard Bertram; Arthur Sherman; Leslie S Satin
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.